Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin Pharmaceutical Investing
Ultragenyx and Kyowa Kirin Announce Crysvita Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia Pharmaceutical Investing
Genocea Files Investigational New Drug Application for Neoantigen Cancer Vaccine Candidate GEN-009 Pharmaceutical Investing
Daré Bioscience announces funding award to further the development of Ovaprene Pharmaceutical Investing
Keryx Biopharmaceuticals Announces Changes to Management and Preliminary First Quarter 2018 Revenue Pharmaceutical Investing
Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma Pharmaceutical Investing
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis Biotech Investing
Teligent Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023 Pharmaceutical Investing
Onconova Therapeutics Announces Pricing of $25.0 Million Upsized Underwritten Public Offering Biotech Investing
AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants Medical Device Investing
